NM_001372.4:c.3369T>C

Variant summary

Our verdict is Benign.
-8 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -8 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_StrongB4_Strong

The NM_001372.4(DNAH9):c.3369T>C (p.Asp1123Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.98 (AC=1,582,196) in the gnomAD database across 1,613,704 control chromosomes, including 776,019 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.986. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.).

Frequency

Genomes: 𝑓 0.97 ( 71261 hom., cov: 32)
Exomes 𝑓: 0.98 ( 704758 hom. )

Consequence

DNAH9
NM_001372.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.277

Publications

16 publications found
Variant links:
Genes affected
DNAH9 (HGNC:2953): (dynein axonemal heavy chain 9) This gene encodes the heavy chain subunit of axonemal dynein, a large multi-subunit molecular motor. Axonemal dynein attaches to microtubules and hydrolyzes ATP to mediate the movement of cilia and flagella. The gene expresses at least two transcript variants; additional variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
DNAH9 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 40
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • situs inversus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001372.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Benign. The variant received -8 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.986 — exceeds 1% threshold (B1 applied)
B4Synonymous/intronic, no splicing impact
Synonymous/intronic variant with confirmed no splicing impact (B4 strong); Synonymous variant — splicing algorithms confirm no impact on splicing (B4 strong [-4])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001372.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

DNAH9 NM_001372.4
MANE Select
HGVSc / HGVSpc.3369T>Cp.Asp1123Asp
Exon rankExon 18 of 69
synonymous
Prot: NP_001363.2UniProt: Q9NYC9-1

Ensembl Transcripts

DNAH9 ENST00000262442.9
TSL:1MANE Select
HGVSc / HGVSpc.3369T>Cp.Asp1123Asp
Exon rankExon 18 of 69
synonymous
Prot: ENSP00000262442.3UniProt: Q9NYC9-1
DNAH9 ENST00000454412.6
TSL:5
HGVSc / HGVSpc.3369T>Cp.Asp1123Asp
Exon rankExon 18 of 68
synonymous
Prot: ENSP00000414874.2UniProt: E7EP17

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.967
AC:147142
Hom:71210
AN:152156
Cov:32
GnomAD2 exomes
AF: 0.972
AC:244454
AN:251422
GnomAD4 exome
AF: 0.982
AC:1434943
Hom:704758
AN:1461430
Cov:40
GnomAD4 genome
AF: 0.967
AC:147253
Hom:71261
AN:152274
Cov:32
TOPMed (Bravo)
AF: 0.962
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.978
AC:221908
Hom:108567
AN:226866
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.962
AC:2253
Hom:1090
AN:2342
ChinaMAP Phase 1
AF: 0.910
Denmark Genome
AF: 1.00
AC:300
AN:300
ESP6500 (Exome Variant Server)
AF: 0.968
AC:12594
AN:13006
GenomeAsia100K
AF: 0.923
AC:3211
AN:3478
Korea4K (4,157 Koreans)
AF: 0.924
AC:6683
AN:7232
Qatari Genome
AF: 0.984
AC:1978
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.899
AC:110431
Hom:49683
AN:122806
Turkish Variome
AF: 0.972
AC:6538
Hom:3183
AN:6724
UK10K
AF: 0.990
AC:7485
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.910
AC:8156
Hom:3719
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.994 *1104311112 0.994 *1750317616
BipEx
(Bipolar disorder (including schizoaffective))
0.991 2815928420 0.990 2854928844
Epi25
(Epilepsy)
0.976 4094641958 0.978 6543966888
SCHEMA
(Schizophrenia)
0.892 158070177146 0.893 268008300016
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Ciliary dyskinesia, primary, 40 (1)

Computational Scores

AlphaGenome AVI
Benign0.84
BayesDel_noAF
Benign-0.84
CADD
Benign0.32
DANN
Benign0.25
GPN-Star LLR
N/A2.2
GPN-Star score
N/A-2.0
Mutation Taster
N/A99/1polymorphism (auto)
PhyloP100
Benign0.28
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.